Target Poor or Non Binder(s) Information
| Target General Information | Top | ||||
|---|---|---|---|---|---|
| Target ID | T63414 | Target Info | |||
| Target Name | P2X purinoceptor 7 (P2RX7) | ||||
| Synonyms |
Purinergic receptor 7; P2Z receptor; P2X7; Adenosine P2X7 receptor; ATP receptor
Click to Show/Hide
|
||||
| Target Type | Clinical trial Target | ||||
| Gene Name | P2RX7 | ||||
| Biochemical Class | ATP-gated P2X receptor cation channel | ||||
| UniProt ID | |||||
| Poor Binders of This Target (in total, 13 binders) | Download | Top | |||
|---|---|---|---|---|---|
| Compound Name |
Suramin
Click to Show/Hide
|
Phase 1 | Compound Info | ||
| Synonyms |
Antrypol; Belganyl; Farma; Fourneau; Germanin; Moranyl; Naganil; Naganin; Naganine; Naganol; Naphuride; SVR; Suramine; SURAMIN SODIUM; Sodium suramin; Suramine sodium; Farma 939; Naganol 6 Na; Germanin (TN); SGCTO-001
Click to Show/Hide
|
||||
| Activity |
EC50 = 92000 nM
|
[1] | |||
| Compound Name |
[3H]alphabeta-meATP
Click to Show/Hide
|
Investigative | Compound Info | ||
| Synonyms |
Diphosphomethylphosphonic acid adenosyl ester; alpha,beta-Methylene ATP; alpha,beta-meATP; 7292-42-4; UNII-NYX13NT29D; diphosphomethylphosphonic acid adenosyl ester; alpha,beta-Methyleneadenosine 5'-triphosphate; EINECS 230-723-9; NYX13NT29D; ALPHA,BETA-METHYLENEADENOSINE-5'-TRIPHOSPHATE; CHEMBL132722; CHEBI:35056; 5'-O-(hydroxy{[hydroxy(phosphonooxy)phosphoryl]methyl}phosphoryl)adenosine; 5'-(Hydrogen((hydroxy(phosphonooxy)phosphinyl)methyl)phosphonate)adenosine; adenosine 5'-[alpha,beta-methylene]triphosphate; AMP-CPP; Adenosine 5'-(hydrogen; Alpha,Beta-Methyleneadenosine-5'-Triphosphate
Click to Show/Hide
|
||||
| Activity |
EC50 ~ 100000 nM
|
[1] | |||
| Compound Name |
A-846714
Click to Show/Hide
|
Investigative | Compound Info | ||
| Synonyms |
JMC516547 Compound 2; A-846714; 2-Aminopyrimidine analog., 4; SCHEMBL2166660; CHEMBL494678; BDBM26229
Click to Show/Hide
|
||||
| Activity |
IC50 ~ 100000 nM
|
[2] | |||
| Compound Name |
Bz-ATP
Click to Show/Hide
|
Investigative | Compound Info | ||
| Synonyms |
CHEMBL339386; BDBM50118219
Click to Show/Hide
|
||||
| Activity |
EC50 = 52000 nM
|
[1] | |||
| Compound Name |
Isoquinoline-5-sulfonic acid 4-[[3-[1-[3-(trifluoromethyl)-4-chlorobenzoyl]-4-piperidinyl]-2,5-dioxoimidazolidine-4-yl]methyl]phenyl ester
Click to Show/Hide
|
Investigative | Compound Info | ||
| Synonyms |
CHEMBL3415342; BDBM50075467
Click to Show/Hide
|
||||
| Activity |
IC50 = 54000 nM
|
[3] | |||
| Compound Name |
N,N-Diethylbenzo[b][1]benzazepine-11-carboxamide
Click to Show/Hide
|
Investigative | Compound Info | ||
| Synonyms |
CHEMBL1483754; N,N-diethyl-5H-dibenzo[b,f]azepine-5-carboxamide; SMR000140783; CBMicro_036220; ChemDiv1_020851; Cambridge id 5904475; MLS000533385; SCHEMBL11125977; HMS646D17; HMS2177K12; ZINC243685; BDBM50446076; STK833366; AKOS001484495; CCG-105876; MCULE-8727147214; BIM-0036300.P001; MLS000533385-02; MLS000533385-03; AB00100428-01; SR-01000425817; SR-01000425817-1
Click to Show/Hide
|
||||
| Activity |
IC50 = 69800 nM
|
[4] | |||
| Compound Name |
N,N-Diisopropyl-5H-dibenzo[b,f]azepine-5-carboxamide
Click to Show/Hide
|
Investigative | Compound Info | ||
| Synonyms |
CHEMBL3103385; BDBM50446060
Click to Show/Hide
|
||||
| Activity |
IC50 = 95200 nM
|
[4] | |||
| Compound Name |
N'-(2-Chlorophenyl)pentacyclo[6.4.0.02,10.03,7.04,9]dodeca-5,11-diene-8-carbohydrazide
Click to Show/Hide
|
Investigative | Compound Info | ||
| Synonyms |
CHEMBL4076285; BDBM50234434
Click to Show/Hide
|
||||
| Activity |
IC50 = 96000 nM
|
[5] | |||
| Compound Name |
(S)-4-(2-(N-Methylisoquinoline-5-sulfonamido)-3-oxo-3-(4-phenylpiperazin-1-yl)propyl)phenyl isoquinoline-5-sulfonate
Click to Show/Hide
|
Investigative | Compound Info | ||
| Synonyms |
KN-62; UNII-63HM46XPOW; CHEMBL28324; KN 62; C38H35N5O6S2; 63HM46XPOW; 1-(N,O-Bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl)-4-phenylpiperazine; 1-[N,O-bis(5-Isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazine; 127191-97-3 (free base); MFCD00083180; 1-[N,O-bis-(5-Isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazine; SMR000058456; KN62 (S isomer); CBiol_002006; Lopac0_000620; MLS000028868; MLS006011204; SCHEMBL379481; GTPL4235; KN-62, >=95%, powder; Bio1_000292; Bio1_000781; Bio1_001270; HMS2235I16; HMS3648M08; HMS3886F15; BCP02708; EX-A2396; ZINC4262461; BDBM50087267; s7422; AKOS005145990; CCG-270407; CS-0516; KS-0000182F; NCGC00162398-01; NCGC00162398-02; NCGC00162398-03; NCGC00162398-04; AC-27760; HY-13290; AB0035818; SW219945-1; Y0221; S-7692; A805658; SR-01000721938; J-005472; KN-62 - CAS 127191-97-3; SR-01000721938-2; Q18386454; 1-[ N,O-Bis(5-isoquinolinesulfonyl)-N-methyltyrosyl]-4-phenylpiperazine; 1-[N,O-Bis(5-Isoquinolinesulfonyl)-N-Methyltyrosyl]-4-Phenylpiperazine; 1-[N,O-Bis(5-isoquinolinesulfonyl)N-methyltyrosyl]-4-phenylpiperazine; (1-(N,O-bis(1,5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl)-4phenylpiperazine); [(1-[N,O-bis(5-isoquinolinesulphonyl)-N-methyl-Ltyrosyl]-4-phenylpiperazine); 1-(N,O-bis(1,5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl)-4-phenylpiperazine
Click to Show/Hide
|
||||
| Activity |
IC50 = 96000 nM
|
[5] | |||
| Compound Name |
Benzo[b][1]benzazepin-11-yl(piperidin-1-yl)methanone
Click to Show/Hide
|
Investigative | Compound Info | ||
| Synonyms |
CHEMBL3103371; Oprea1_032507; Oprea1_519310; SCHEMBL11112750; HMS1671L10; ZINC191136; BDBM50446070; CCG-20442; AKOS000573514
Click to Show/Hide
|
||||
| Activity |
IC50 ~ 100000 nM
|
[4] | |||
| Compound Name |
Dibenzo[b,f]azepin-5-yl pyrrolidinyl ketone
Click to Show/Hide
|
Investigative | Compound Info | ||
| Synonyms |
CHEMBL3103372; Oprea1_069626; Oprea1_338062; HMS1673A03; ZINC271506; BDBM50446069; STK368633; AKOS000573479; MCULE-6476076046; ST50728730; 5H-dibenzo[b,f]azepin-5-yl(pyrrolidin-1-yl)methanone
Click to Show/Hide
|
||||
| Activity |
IC50 ~ 100000 nM
|
[4] | |||
| Compound Name |
N,N-Dipropylbenzo[b][1]benzazepine-11-carboxamide
Click to Show/Hide
|
Investigative | Compound Info | ||
| Synonyms |
CHEMBL3103375; BDBM50446068
Click to Show/Hide
|
||||
| Activity |
IC50 ~ 100000 nM
|
[4] | |||
| Compound Name |
N'-[2-(Trifluoromethyl)phenyl]pentacyclo[6.4.0.02,10.03,7.04,9]dodeca-5,11-diene-8-carbohydrazide
Click to Show/Hide
|
Investigative | Compound Info | ||
| Synonyms |
CHEMBL4074868; BDBM50234430
Click to Show/Hide
|
||||
| Activity |
IC50 = 132000 nM
|
[5] | |||
| Click to Show/Hide the Information of All Poor Binders | |||||
| Non Binders of This Target (in total, 4 non binders) | Download | Top | |||
|---|---|---|---|---|---|
| Compound Name |
N'-[2-(Trifluoromethyl)phenyl]pentacyclo[6.4.0.02,10.03,7.04,9]dodecane-8-carbohydrazide
Click to Show/Hide
|
Investigative | Compound Info | ||
| Synonyms |
CHEMBL4075515; BDBM50234432
Click to Show/Hide
|
||||
| Activity |
IC50 = 366000 nM
|
[5] | |||
| Compound Name |
N'-(2-Chlorophenyl)pentacyclo[6.4.0.02,10.03,7.04,9]dodecane-8-carbohydrazide
Click to Show/Hide
|
Investigative | Compound Info | ||
| Synonyms |
CHEMBL4087608; BDBM50234435
Click to Show/Hide
|
||||
| Activity |
IC50 = 933000 nM
|
[5] | |||
| Compound Name |
N'-[2-Chloro-4-(trifluoromethyl)phenyl]pentacyclo[6.4.0.02,10.03,7.04,9]dodeca-5,11-diene-8-carbohydrazide
Click to Show/Hide
|
Investigative | Compound Info | ||
| Synonyms |
CHEMBL4066254; BDBM50234431
Click to Show/Hide
|
||||
| Activity |
IC50 = 1557000 nM
|
[5] | |||
| Compound Name |
Click to Show/Hide
|
Compound Info | |||
| Activity |
EC50 = 780000 nM
|
[1] | |||
| References | Top | ||||
|---|---|---|---|---|---|
| REF 1 | Purine and pyrimidine (P2) receptors as drug targets. J Med Chem. 2002 Sep 12;45(19):4057-93. | ||||
| REF 2 | Structure-activity studies on a series of a 2-aminopyrimidine-containing histamine H4 receptor ligands. J Med Chem. 2008 Oct 23;51(20):6571-80. | ||||
| REF 3 | Discovery of novel 2,5-dioxoimidazolidine-based P2X(7) receptor antagonists as constrained analogues of KN62. J Med Chem. 2015 Mar 12;58(5):2114-34. | ||||
| REF 4 | Carbamazepine derivatives with P2X4 receptor-blocking activity. Bioorg Med Chem. 2014 Feb 1;22(3):1077-88. | ||||
| REF 5 | Escape from adamantane: Scaffold optimization of novel P2X7 antagonists featuring complex polycycles. Bioorg Med Chem Lett. 2017 Feb 15;27(4):759-763. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.